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Abstract. 
 
To investigate the role of protein kinase C 
(PKC) isoforms in regulation of neurite outgrowth, 
 
PKC
 
a
 
, 
 
b
 
II, 
 
d
 
, and 
 
e
 
 fused to enhanced green ﬂuores-
cent protein (EGFP) were transiently overexpressed in 
neuroblastoma cells. Overexpression of PKC
 
e
 
–EGFP 
induced cell processes whereas the other isoforms did 
not. The effect of PKC
 
e
 
–EGFP was not suppressed by 
the PKC inhibitor GF109203X. Instead, process forma-
tion was more pronounced when the regulatory domain 
was introduced. Overexpression of various fragments 
from PKC
 
e
 
 regulatory domain revealed that a region 
encompassing the pseudosubstrate, the two C1 do-
mains, and parts of the V3 region were necessary and 
sufﬁcient for induction of processes. By deleting the 
second C1 domain from this construct, a dominant-neg-
ative protein was generated which suppressed pro-
cesses induced by full-length PKC
 
e
 
 and neurites in-
duced during retinoic acid- and growth factor–induced 
differentiation. As with neurites in differentiated neu-
roblastoma cells, processes induced by the PKC
 
e
 
–
PSC1V3 protein contained 
 
a
 
-tubulin, neuroﬁlament-
160, and F-actin, but the PKC
 
e
 
–PSC1V3-induced
processes lacked the synaptic markers synaptophysin 
and neuropeptide Y. These data suggest that PKC
 
e
 
, 
through its regulatory domain, can induce immature 
neurite-like processes via a mechanism that appears to 
be of importance for neurite outgrowth during neu-
ronal differentiation.
Key words: C1 domains • neuroblastoma cells • neu-
ronal differentiation • neurite outgrowth • protein ki-
nase C
 
T
 
HE
 
 regulation of neurite outgrowth during neuronal
differentiation is complex and likely to involve mul-
tiple signal transduction components. One group of
enzymes that has been suggested to be involved in this
process is the protein kinase C (PKC)
 
1
 
 isoform family.
Several PKC isoforms have been shown to be present in
growing axons both in vivo and in vitro (Ide, 1996). There
is also experimental evidence for a function of PKC in the
regulation of neurite outgrowth in neuronal differentia-
tion model systems, such as PC12 cells (Hundle et al.,
1995, 1997) and neuroblastoma cells (Parrow et al., 1992,
1995; Fagerström et al., 1996).
PKC comprises a family of serine/threonine protein ki-
nases, consisting of at least 11 different isoforms, divided
into subgroups depending on structural similarities and re-
quirement for activators. The classical PKCs (
 
a
 
, 
 
b
 
I, 
 
b
 
II,
 
and 
 
g
 
) are Ca
 
2
 
1
 
-dependent and activated by diacylglycerol
and phorbol esters. Novel PKCs (
 
d
 
, 
 
e
 
, 
 
h
 
, and 
 
u
 
) are acti-
vated by diacylglycerol and phorbol esters, but are Ca
 
2
 
1
 
-
independent. The atypical PKC isoforms 
 
z
 
 and 
 
i
 
/
 
l
 
 are in-
sensitive to diacylglycerol and phorbol ester and are also
Ca
 
2
 
1
 
-independent. Finally, PKC
 
m 
 
is structurally unique,
but is activated by phorbol esters (Nishizuka, 1992; New-
ton, 1995; Liu, 1996).
The PKC molecule consists of one NH
 
2
 
-terminal regula-
tory domain (RD) and one COOH-terminal catalytic do-
main. In the resting state the enzyme is kept inactive by a
pseudosubstrate motif in the RD bound to the catalytic
site. To become active this locked conformation has to be
changed and this is assumed to be caused by the binding of
activators to the RD (Newton, 1997). The RD from classi-
cal and novel PKC isoforms contains two classes of do-
mains, C1 and C2, which are targets for PKC activators.
Diacylglycerol and phorbol ester bind C1 domains and in
classical isoforms the C2 domain binds Ca
 
2
 
1
 
. On the other
hand, the C2 domain in novel isoforms does not bind Ca
 
2
 
1
 
,
putatively explaining the Ca
 
2
 
1
 
 independence of these iso-
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1. 
 
Abbreviations used in this paper:
 
 CNTF, ciliary neurotrophic factor;
EGFP, enhanced green fluorescent protein; FL, full-length PKC; FLE,
full-length PKC bound to EGFP; GFP, green fluorescent protein; NF-160,
 
neurofilament-160; NPY, neuropeptide Y; PKC, protein kinase C; RA, ret-
inoic acid; RACK, receptor for activated C-kinase; RD, regulatory do-
main; TPA, 12-
 
O
 
-tetradecanoylphorbol-13-acetate. 
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forms (Stabel and Parker, 1991; Nishizuka, 1992; Ponting
and Parker, 1996).
Besides being the target for PKC activators, the RD also
has been shown to be responsible for protein–protein in-
teraction, which may direct each isoform to unique intra-
cellular sites. RACKs (receptors for activated C-kinase)
constitute one class of PKC-binding proteins that interact
with activated PKC and this binding is to a large extent
mediated via the C2 domain (Mochly-Rosen and Gordon,
1998). RACKs have been identified for PKC
 
b
 
 (Ron et al.,
1994) and 
 
e
 
 (Csukai et al., 1997), and overexpression of ei-
ther the entire C2 domain or peptides derived thereof has
been shown to block isoform-specific translocation and/or
activation of individual isoforms (Ron et al., 1995; Johnson
et al., 1996; Hundle et al., 1997). There are also several re-
ports demonstrating protein interaction sites in the region
comprising the two C1 domains (Prekeris et al., 1996;
Matto-Yelin et al., 1997; Yao et al., 1997), suggesting that
depending on the interaction partner, different PKC do-
mains may be of importance. Since there is little evidence
for a substrate of PKC that is preferentially phosphory-
lated by one or several isoforms, but not by others, at least
some of the isoform-specific effects observed have been
attributed to the fact that different isoforms will localize to
different intracellular sites. Due to these assumptions, and
since RDs in several cases determine interaction partners
and subcellular localization sites, RDs have been consid-
ered to be acting isoform specifically in a dominant-nega-
tive manner (Jaken, 1996). Studies have shown specific ef-
fects of overexpression of RDs from individual isoforms
(Liao et al., 1994; Cai et al., 1997). However, there are also
reports demonstrating that the effect of the full-length
PKC can be mimicked by parts of, or the entire, RD indi-
cating that some PKC effects may actually be mediated via
this domain (Lehel et al., 1995a; Singer et al., 1996). Fur-
thermore, studies with chimeras consisting of PKC mole-
cules with the regulatory and catalytic domain derived
from different isoforms have shown that isoform specific-
ity may be mediated via either domain (Acs et al., 1997;
Wang et al., 1998). Thus, to understand the molecular
mechanisms for a PKC effect there is a need to identify
which isoforms exert the effect and which domain(s) is/are
involved in mediating it.
Neuroblastoma cell lines have been used extensively as
in vitro model systems to study mechanisms regulating
neuronal differentiation. In this study, two neuroblastoma
cell lines, SH-SY5Y and SK-N-BE(2), were used. Both of
these cell lines can be induced to differentiate with a pleth-
 
ora of factors (Påhlman et al., 1981; Melino et al., 1993;
Lavenius et al., 1994, 1995; Rossino et al., 1995). In several
of these differentiation protocols there is evidence for the
involvement of PKC. In particular, neurite outgrowth ap-
pears to involve PKC, and a number of PKC isoforms are
present in growth cones of the differentiating cells (Par-
row et al., 1995; Fagerström et al., 1996). Experiments with
high phorbol ester concentrations, which cause selective
down regulation of PKC isoforms, have suggested that
novel isoforms may be of importance in neurite outgrowth
(Fagerström et al., 1996).
The aim of this study was to investigate whether in-
creased levels of a particular PKC isoform would be suffi-
cient to induce growth of neurites in neuroblastoma cells.
To accomplish this, cDNA coding for the classical and
novel PKC isoforms that are consistently expressed in
neuroblastoma cell lines and tumor specimens, PKC
 
a
 
, 
 
b
 
II,
 
d
 
, and 
 
e
 
 (Zeidman et al., 1999), was introduced into an ex-
pression vector and human neuroblastoma cells were
transfected with these plasmids. To identify cells overex-
pressing the proteins, the COOH-terminal ends of the iso-
forms were fused to enhanced green fluorescent protein
(EGFP). The results demonstrate that PKC
 
e
 
 is the only
isoform that can induce processes in neuroblastoma cells
and that this effect is independent of the catalytic activity
of the enzyme. By making a series of constructs expressing
isolated domains of PKC
 
e
 
, this study demonstrates that
the effect is mediated by a region from PKC
 
e
 
 encompass-
ing the pseudosubstrate, the two C1 domains, and parts of
the V3 region. The data also indicate that this effect is of
importance for neurite outgrowth during neuronal differ-
entiation.
 
Materials and Methods
 
Plasmids
 
cDNA coding for full-length human PKC isoforms 
 
a
 
, 
 
b
 
II, 
 
d
 
, and 
 
e
 
; the RD
from PKC
 
a
 
, 
 
b
 
II, 
 
d
 
, 
 
e
 
, 
 
h
 
, and 
 
u
 
; or smaller fragments of PKC
 
e
 
 were gener-
ated by PCR with introduction of appropriate restriction enzyme sites in
the primers. The DNA fragments were introduced into the pEGFP-N1
vector (Clontech Laboratories, Inc.), thereby fusing the PKC cDNA with
EGFP cDNA. The schematic structures of the protein products coded for
by the different expression vectors are shown in Fig. 1 A. Templates for
the PCR reactions were for PKC
 
a
 
, 
 
e
 
, and 
 
u
 
 cDNA from SH-SY5Y cells;
for PKC
 
b
 
II ATCC plasmid 80047 (Hocevar et al., 1993); for PKC
 
d
 
 ATCC
plasmid 80049 (Aris et al., 1993); and for PKC
 
h
 
 cDNA generated from
human placenta mRNA (Clontech Laboratories, Inc.). The PKC
 
e
 
 plas-
mids 
 
e
 
PSC1aV3E
 
 and 
 
e
 
PSC1bV3E
 
 (
 
e
 
PSC1V3E
 
 with DNA coding for ei-
ther the second or the first C1 domain deleted) were generated with prim-
 
Figure 1.
 
PKC–EGFP fusion constructs used in this study. (A) List of PKC constructs produced for this study. The left column shows
schematic composition of PKC
 
e
 
 fragments coded for by the expression vectors used in this study: PS (pseudosubstrate), C1, C2, and V3
domains. The primers used for amplification of the cDNA fragments are listed in Table I. The predicted molecular weights of the fusion
proteins are included. (B–D) COS cells were transfected with the plasmids listed in A and the formation of the protein products were
analyzed with Western blot technique. (B) Analysis of full-length PKC isoforms 
 
a
 
, 
 
b
 
II, 
 
d
 
, and 
 
e
 
 fused to EGFP (
 
1
 
) or expressed with-
out any tags (
 
2
 
). Immunoblots were performed with isoform-specific antibodies. Arrows indicate reactivity corresponding to PKC–
EGFP fusion proteins and arrowheads point to the untagged PKC isoforms. The presence of full-length PKC
 
a
 
, 
 
b
 
II, and 
 
d
 
 immuno-
reactivity in cell lysates from cells overexpressing EGFP fusions indicates endogenous levels of respective isoform in COS cells. The
positions of two weight markers, 97 and 66 kD, are included to the left of the blots. (C) Analysis of RDs from PKC
 
a
 
, 
 
b
 
I/II, 
 
d
 
, 
 
e
 
, 
 
h
 
, and 
 
u
 
fused to EGFP. Cell lysates from COS cells transfected with respective expression vectors were analyzed with immunoblot using an
anti-GFP antibody as primary antibody. The positions of three weight markers, 97, 66, and 46 kD, are included to the left of the blot.
(D) Analysis of PKC
 
e
 
 subdomains fused to EGFP. Cell lysates from COS cells transfected with respective expression vectors were ana- 
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lyzed with immunoblot using an anti-GFP antibody as primary antibody. The positions of three weight markers, 66, 46, and 30 kD, are
included to the left of the blots. U denotes an unspecific band at 
 
z
 
55 kD, which appeared in some immunoblots in C and D, when using
the GFP antibody on COS cell lysates. 
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ers designed to amplify the entire 
 
e
 
PSC1V3E
 
 plasmid, excluding the DNA
coding for the domain that should be deleted. An MluI site was intro-
duced in each primer, the PCR product was cleaved with MluI, and li-
gated. Table I lists the primers used to generate the PKC fragments. All
PCR reactions were performed with 
 
Pfu
 
 polymerase (Stratagene) to mini-
mize introduction of mutations and all PCR-generated fragments used in
this study were sequenced. The generation of the protein products of an-
ticipated sizes were confirmed by transfecting the expression vectors into
COS cells with the calcium phosphate method (Sambrook et al., 1989) and
subjecting the cell lysate to Western blot analysis (Fig. 1, B–D). In addi-
tion, the NheI/SalI fragments from 
 
a
 
FL
 
 and 
 
e
 
FL
 
 (full-length PKC) were
inserted into the CMS–EGFP vector (Clontech Laboratories, Inc.) to ob-
tain expression of PKC and EGFP as two separate proteins.
 
Western Blot Analysis
 
COS cells were transfected with different expression vectors, washed with
PBS, and lysed in buffer (10 mM Tris, pH 7.2, 160 mM NaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 1 mM
EGTA, 1 mM EDTA, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, and 1 mM
phenylmethylsulfonyl fluoride). Lysates were centrifuged for 10 min at
15,000 
 
g
 
 and 25 
 
m
 
g of protein was electrophoretically separated on an SDS
polyacrylamide gel and thereafter transferred to Hybond-C extra nitrocel-
lulose filter (Nycomed-Amersham, Inc.). EGFP- or PKC-immunoreactiv-
ity was analyzed with antibodies directed against green fluorescent pro-
tein (GFP; Clontech Laboratories, Inc.) or PKC
 
a
 
, 
 
b
 
II, 
 
d
 
, or 
 
e
 
 (Santa
Cruz), and detected with an HRP-labeled secondary antibody using the
SuperSignal system (Pierce Chemical Co.) as substrate. The chemilumi-
nescence was detected with a CCD camera (Fuji Photo Film Co.).
 
Cell Culture
 
Human neuroblastoma SH-SY5Y, SH-SY5Y/TrkA, and SK-N-BE(2)
cells were maintained in MEM supplemented with 10% FBS, 100 IU/ml
penicillin, and 100 
 
m
 
g/ml streptomycin (GIBCO BRL). For transfection
experiments, SH-SY5Y and SH-SY5Y/TrkA cells were trypsinized and
 
seeded at a density of 350,000 cells/35-mm cell culture dish on glass cover-
slips in serum free medium. After 20 min the medium was changed to me-
dium containing serum and antibiotics, and incubated for 24 h before start
of the transfections. SK-N-BE(2) cells were seeded on glass coverslips in
regular growth medium (300,000 cells per dish) and transfections were ini-
tiated 24 h after seeding. In experiments where cells were treated with 12-
 
O
 
-tetradecanoylphorbol-13-acetate (TPA; Sigma Chemical Co.) for 4 d,
or with growth factors for 40 h, the density at cell seeding was 250,000
cells/35-mm dish.
SH-SY5Y cells were transfected using 3.5 
 
m
 
l Lipofectin (GIBCO BRL)
and 1.8 
 
m
 
g of DNA/ml serum free medium and SK-N-BE(2) cells were
transfected with 4 
 
m
 
l Lipofectamine (GIBCO BRL) and 2 
 
m
 
g DNA, es-
sentially according the supplier’s protocol.
For differentiation studies, SH-SY5Y/TrkA cells were treated for 40 h
with 100 ng/ml NGF (Promega Corp.), and SK-N-BE(2) cells with 10 
 
m
 
M
retinoic acid (RA; Sigma Chemical Co.) or 25 ng/ml ciliary neurotrophic
factor (CNTF; Promega Corp.).
 
Morphology Studies
 
16 h after the end of transfections (unless otherwise stated) cells were
fixed in 4% paraformaldehyde in PBS for 4 min, mounted on microscopy
slides using a PVA-DABCO solution (9.6% polyvinyl alcohol, 24% glyc-
erol, and 2.5% 1,4-diazabicyclo[2.2.2]octane in 67 mM Tris-HCl, pH 8.0),
and used for morphological studies. Digital images were captured with a
Sony DKC 5000 camera system. The transfected cells were considered to
have long processes if the length of the process exceeded that of two cell
bodies. At least 200 transfected cells per experiment were counted.
 
Confocal Microscopy
 
Cells were transfected, fixed, and mounted as for morphology studies.
Cells expressing various PKC
 
e
 
–EGFP constructs and Texas red–phalloi-
din-stained F-actin were examined using a Bio-Rad MRC 1024 confocal
system fitted with a Nikon Diaphot 300 microscope using a Nikon plan-
apo 60 
 
3
 
 1.2 NA water immersion lens.
 
Immunofluorescence and Staining of F-Actin
 
Cells grown on glass coverslips were fixed with 4% paraformaldehyde as
above. For detection of 
 
a
 
-tubulin, synaptophysin, and neuropeptide Y
(NPY), cells were permeabilized and blocked with 1% BSA/0.02% sapo-
nin in PBS. The primary antibody (monoclonal mouse anti–
 
a
 
-tubulin
[Sigma Chemical Co.] diluted to 1:2,000; monoclonal mouse antisynapto-
physin [clone SY38, DAKOPATTS] diluted to 1:10; or polyclonal rabbit
anti–NPY [Biogenesis] diluted to 1:40, respectively) was incubated for 1 h
in blocking/permeabilization solution. The secondary antibody (donkey
anti–mouse IgG-TRITC [Jackson ImmunoResearch Laboratories, Inc.]
diluted to 1:100 for 
 
a
 
-tubulin and 1:20 for synaptophysin detection; or
donkey anti–rabbit IgG-TRITC [Jackson ImmunoResearch Laboratories,
Inc.] diluted to 1:300 for NPY staining) was incubated for 1 h in blocking
solution. Extensive washing with PBS and blocking/permeabilization solu-
tion was done between all steps. For detection of neurofilament-160 (NF-
160), cells were blocked for 30 min with 3% BSA in PBS and incubation
with monoclonal mouse anti–NF-160 (Sigma Chemical Co.) diluted to
1:50 was performed for 3 h. Secondary antibody donkey anti–mouse IgG-
TRITC (Jackson ImmunoResearch Laboratories, Inc.) was diluted to
1:300 and incubated for 1 h after extensive washing with PBS. For staining
of F-actin, cells were fixed with 4% paraformaldehyde. Cells were treated
for 5 min with 0.1% Triton X-100 in PBS and incubated for 10 min with 2
 
m
 
g/ml TRITC–conjugated phalloidin (Sigma Chemical Co.) in PBS. For
confocal studies, fixed cells were blocked and permeabilized with 5% don-
key serum and 0.3% Triton X-100 in TBS, and stained for 20 min with
Texas red–conjugated phalloidin (Molecular Probes, Inc.; 25 
 
m
 
l/ml block-
ing/permeabilization solution). Coverslips were mounted on object slides
with 20 
 
m
 
l PVA-DABCO.
Results
PKCe Induces Processes in Neuroblastoma Cells
To investigate whether increased levels of a specific PKC
isoform are sufficient to induce neurites, expression vec-
tors coding for four different PKC isoforms were trans-
Table I. Primers Used to Amplify PKC cDNA
Primer Sequence
AF1 GGAAGATCTGGACCATGGCTGACGTTTTC
AR1 CGCGTCGACTCATACTGCACTCTGTAAGAT
AR2 CGCGTCGACCATACTGCACTCTGTAAGATG
AR3 AACGTCGACGCAGGGCCAAGTTTGGCTTT
B2F1 GGAAGATCTGCAAGATGGCTGACCCGGCT
B2R1 CGCGTCGACTTAGCTCTTGACTTCGGGTTT
B2R2 CGCGTCGACAAGCTCTTGACTTCGGGTTTTA
B2R3 AACGTCGACTGACTGATCTTGGCCCTCTC
DF1 CGCCTCGAGCCCACCATGGCGCCGTTCCTGCGCATC
DF2 GGAAGATCTGCAACGGGAGCCCCACTGCA
DR1 CGCGAATTCAATCTTCCAGGAGGTGCTCG
DR2 CGCGAATTCGATCTTCCAGGAGGTGCTCGAATT
DR3 CGGAATTCTACCCTGATATATCCCAACA
EF1 GGAAGATCTCGACCATGGTAGTGTTCAAT
EF2 CGCAGATCTCGACCATGGGTGAAGCCCCTAAAGACAAT
EF3 CGCAGATCTCGACCATGGGCCACAAGTTCATGGCCACC
EF4 GCGACGCGTACCCCCGACCAGGTGGGCTCC
EF5 GCGACGCGTGCCAAAGTACTGGCCGACCTG
ER1 CGCGTCGACTCAGGGCATCAGGTCTTCACC
ER2 CGCGTCGACCAGGGCATCAGGTCTTCACCA
ER3 AACGTCGACTCTCCTCGGTTGTCAAATGA
ER4 CGCGTCGACATTCCTCTGGCATCCACTCC
ER5 CGCGTCGACCGAAGATAGGTGGCCATGAA
ER6 CGCGTCGACACACGCTCTTCATTGTCTT
ER7 CGCGTCGACACCTGGTCGGGGGTCTCCTG
ER8 GCGACGCGTGGCCATGAACTTGTGGCCGTT
ER9 GCGACGCGTGATACCGAACTTGTGGGGCAT
HF1 GCAAGATCTGCATGTCGTCTGGCACCATG
HR1 GCAGTCGACCCAATCCCATTTCCTTC
QF1 GCAGGATCCCCATGTCGCCATTTCTTCG
QR1 GCTGTCGACCAGGAAATGCCCTGAGGCTCZeidman et al. PKCe Regulatory Domain Induces Processes 717
fected into neuroblastoma cells. The classical and novel
isoforms consistently expressed in neuroblastoma cells,
PKCa, PKCbII, PKCd, and PKCe (Zeidman et al., 1999),
were selected for this approach. The cDNAs coding for
these isoforms were fused to cDNA coding for EGFP,
generating a PKC–EGFP fusion protein when expressed.
To confirm the generation of fusion proteins, COS cells
were transiently transfected with these plasmids, and cell
lysates were subjected to Western blot analysis using iso-
form-specific antibodies (Fig. 1 B), which demonstrated
the formation of proteins of the anticipated sizes.
SH-SY5Y and SK-N-BE(2) neuroblastoma cells were
transfected with the vectors and the morphology of trans-
fected cells was visualized with fluorescence microscopy
(Fig. 2 A). When EGFP alone was expressed in SH-SY5Y
and SK-N-BE(2) cells, the fluorescence was distributed
throughout the cell. aFLE and bIIFLE (full-length PKC
bound to EGFP) were mainly localized in the cytoplasm
and were absent from the nucleus. dFLE localized
throughout the entire cell, whereas eFLE localized mainly
to the cell periphery and, in some cells, to perinuclear
structures (Fig. 2 A). All fusion proteins gave rise to fluo-
rescence of similar intensity in the transfected cells, indi-
cating that there were no major differences in the expres-
sion levels of fusion proteins in individual cells.
The morphological effects of the overexpression of PKC
isoforms were quantified by counting the number of trans-
fected cells with cell processes longer than the length of
two cell bodies. In SK-N-BE(2) cells, overexpression of
eFLE induced long processes in 41% of the transfected
cells, a substantially higher number than cells expressing
EGFP only, where 6% of transfected cells had long pro-
cesses. This effect was specific for PKCe, as overexpres-
sion of neither aFLE, bIIFLE, nor dFLE resulted in an in-
creased number of cells with long processes (Fig. 2 B). A
similar, but less pronounced pattern was observed in SH-
SY5Y cells where overexpression of eFLE lead to 23%
transfectants with long processes compared with 12% for
cells expressing EGFP only. As in the case of the SK-
N-BE(2) cells, overexpression of other PKC isoforms did
not induce processes (Fig. 2 C). To exclude a potential role
of EGFP in the PKCe effect, cDNA for PKCa and e were
transferred from aFL and eFL, respectively, to the CMS–
EGFP vector as a control. In these constructs PKC and
Figure 2. Induction of processes
by PKCe–EGFP overexpression.
SH-SY5Y and SK-N-BE(2) cells
were transfected with CMV-
driven expression vectors con-
taining cDNA for PKCa ( a),
PKCbII (b), PKCd (d), or PKCe
(e) fused to EGFP or vector cod-
ing for EGFP only (2). Cells
were fixed 16 h after transfection
and mounted on object slides.
(A) Fluorescence images of
cells  expressing PKC–EGFP fu-
sion proteins. Comparison with
bright-field microscopy images
showed that the fluorescence
from the PKC–EGFP fusion pro-
tein made the entire cell visible.
The cells shown are typical for
each treatment. For PKCe cells
with processes are shown. (B and
C) Quantification of the morpho-
logical effects shown in A. The
number of transfected SK-N-BE(2)
(B) and SH-SY5Y (C) cells with
processes longer than the length
of two cell bodies were counted.
Data (mean 6 SEM, n 5 3) are
presented as percent transfected
cells with long processes. (D) Fol-
lowing transfection of SH-SY5Y
and SK-N-BE(2) cells with EGFP
or eFLE. 2 mM GF109203X was
added to the medium. Cells were
fixed 16 h after transfection and
the number of cells with long
processes were counted. Data
(mean  6 SEM, n 5 2) are pre-
sented as transfected cells with
long processes.The Journal of Cell Biology, Volume 145, 1999 718
EGFP are expressed as separate proteins. SK-N-BE(2)
cells were transfected with these vectors, and 5% of PKCa
and 31% of PKCe overexpressing cells had processes. This
demonstrates that the process induction of PKCe–EGFP is
not dependent on EGFP.
To investigate whether the changes in cell morphology
provoked by overexpression of PKCe–EGFP can be blocked
by inhibition of PKC, the transfectants were treated with
GF109203X (Fig. 2 D). This inhibitor did not cause a de-
crease in the percentage of transfected cells with long pro-
cesses. The concentration used (2 mM) is in the range that
inhibits the catalytic activity of classical and novel PKC
isoforms in vitro (Martiny-Baron et al., 1993) and blocks
TPA-induced expression of fos and jun genes in neuro-
blastoma cells (Ding et al., 1998). Thus, the induction of
processes by PKCe appears to be independent of the cata-
lytic activity of the enzyme.
The Regulatory Domain of PKCe Is Sufficient to
Induce Processes
The fact that overexpression of full-length PKCe induced
processes in the presence of GF109203X suggested an in-
dependence of the kinase activity. To analyze whether the
PKC RD is sufficient for the effect, vectors coding for the
RDs of PKCa, b, d, and e fused to EGFP, were created.
The RDs of the remaining novel isoforms PKCh and
PKCu, which are not expressed in neuroblastoma cells,
were also included as a comparison (Fig. 1 A). All con-
structs were sequenced and found free of mutations. The
constructs were expressed in COS cells (Fig. 1 C) where
Western blot analysis confirmed formation of proteins of
the anticipated sizes.
SH-SY5Y and SK-N-BE(2) cells were transfected with
the vectors and all fusion proteins gave rise to fluores-
cence of similar intensity in transfected cells (Fig. 3), with
the exception of uRDE. uRDE caused a weaker fluores-
cence suggesting lower levels of this protein. As in the case
for full-length PKCa and PKCbII, their corresponding
RD–EGFP fusion proteins localized mainly outside the
nucleus with a tendency to perinuclear enrichment (Fig. 3
A). Neither of these RDs induced a major increase in the
number of cells with processes (Fig. 3, B and C). In
contrast, transfection with the dRDE, eRDE, and hRDE
constructs led to a drastic change in cell morphology,
most prominent in eRDE transfectants. Overexpression of
these proteins gave rise to 19% (dRDE), 32% (eRDE),
and 25% (hRDE) SH-SY5Y cells with long processes. The
corresponding numbers for SK-N-BE(2) cells were 55%
(dRDE), 56% (eRDE), and 46% (hRDE). The fusion pro-
teins seemed to be localized mainly to perinuclear struc-
tures and the cell periphery. uRDE seemed to localize to
all parts of the cells and long processes were induced in
12% of the transfected SH-SY5Y cells and 20% of the SK-
N-BE(2) cells.
The Pseudosubstrate, C1 Domains, and Parts of the
V3 Domain from PKCe Are Required for
Process Induction
To clarify which parts of the RD that are essential for the
induction of processes, a series of constructs coding for dif-
ferent parts of eRDE was created (Fig. 1 A). The con-
structs were sequenced and transfected into COS cells,
where proteins of expected sizes were detected in cell ly-
sates with Western blot analysis using a GFP antibody
(Fig. 1 D). The PKCe subdomains were expressed in SH-
SY5Y (Fig. 4, A and B) and SK-N-BE(2) cells (Fig. 4 C),
and proteins gave rise to bright fluorescence of similar in-
tensity suggesting no major difference in intracellular con-
centration.
All fusion proteins containing the two C1 domains
(eRDE,  eC2PSC1E,  ePSC1E,  ePSC1V3E,  eC1V3E, and
eC1E; see Fig. 1 A for structural description) were not de-
tected in the nucleus, and displayed a tendency to enrich in
perinuclear structures (Fig. 4 A). Some fusion proteins,
particularly  eRDE and ePSC1V3E, also seemed to localize
to the plasma membrane. C2-containing proteins without
the C1 domains (eC2E and eC2PSE; see Fig. 1 A) local-
ized throughout the cell, and the smaller proteins (ePSE
and ePSC1aE) were primarily present in the nucleus.
When cell morphology was examined, it was evident
that the fragment from PKCe containing the pseudosub-
strate, the C1 domains, and the V3 region (ePSC1V3E)
was necessary and sufficient to induce processes (Fig. 4,
A–C). 48% of the SH-SY5Y cells expressing this pro-
tein exhibited long processes. In SK-N-BE(2), the corre-
sponding number was 59%. When the pseudosubstrate
(eC1V3E) or the V3 (ePSC1E) was removed from the
PSC1V3 fragment, no substantial induction of processes
could be observed in either cell line. It is notable that in
SH-SY5Y cells more ePSC1V3- than eRDE-expressing
cells had processes (48% versus 36%), suggesting that re-
moval of the C2 domain enhances the process-inducing ca-
pacity (Fig. 4 B). It was also evident that the other con-
structs did not have a major effect on process induction.
Intracellular Distribution of PKCe
Subdomain Fragments
Fluorescence microscopy suggested that the PKCe frag-
ments localized to different intracellular sites. To investi-
gate a possible correlation between the localization and
process-inducing ability of the fragments, transfected SH-
SY5Y cells were analyzed with confocal microscopy (Fig.
5). Full-length PKCe fused to EGFP localized uniformly
outside the nucleus. The smallest fragment that induced
processes, ePSC1V3E, displayed a distinct plasma mem-
brane localization. Removal of the pseudosubstrate led to
the complete loss of plasma membrane localization, as
eC1V3E could only be seen in the perinuclear area of the
cell. This suggests that the pseudosubstrate might be nec-
essary for targeting of PKCe to the plasma membrane
(Fig. 5). Removal of the hinge region from the PSC1V3
fragment generating ePSC1E, which is incapable of induc-
ing processes, did not cause a loss of plasma membrane lo-
calization (Fig. 5). In conclusion, these data suggest that
localization to the plasma membrane, for which the pseu-
dosubstrate and the C1 domains are required, is necessary,
but not sufficient for the process induction. The V3 region
needs to be present for optimal function of the fragment.
Inhibition of Process Outgrowth by the Use of 
Inhibitory PKCe Constructs
The previous results demonstrate that PKCe through theZeidman et al. PKCe Regulatory Domain Induces Processes 719
PSC1V3 fragment has the capacity to induce processes in
neuroblastoma cells. To address the question of whether
this capacity is a part of the molecular events driving neu-
rite outgrowth in neuroblastoma cells differentiating in re-
sponse to growth factors and RA, an attempt was made to
find an ePSC1V3E-derived construct that could inhibit the
process formation, putatively by acting in a dominant-neg-
ative manner. The two constructs that were most similar to
ePSC1V3E, i.e., ePSC1E and eC1V3E, and did not display
a process-inducing capacity, were initially evaluated for
this purpose. Neither construct had a major effect on neu-
rite outgrowth in RA-differentiated SK-N-BE(2) cells
(data not shown). Thereafter, cDNA coding for either the
first (C1a) or the second (C1b) C1 domain was deleted
in the ePSC1V3E construct, forming ePSC1bV3E and
ePSC1aV3E, respectively (Fig. 1, A and D). SK-N-BE(2)
cells were transfected with these vectors, and vector cod-
ing for EGFP only (Fig. 6 A). Neither protein induced
processes in untreated cells, demonstrating that both C1
domains are required for this effect. In fact, there was a
slight suppression of the number of cells with processes in
ePSC1aV3E-expressing cells (Fig. 6 A). After treatment
with RA, 57% of EGFP-expressing cells and 52% of
ePSC1bV3E-transfected cells had neurites. In contrast,
only 18% of ePSC1aV3E-expressing cells had processes,
demonstrating a neurite suppressing effect of this protein.
Treatment with CNTF gave results that followed the same
pattern as in RA, albeit with generally fewer neurite ex-
tending cells (Fig. 6 A).
The constructs were also evaluated for NGF-driven neu-
rite outgrowth of SH-SY5Y cells stably expressing the
high affinity NGF receptor, TrkA (Fig. 6 B). Also in this
differentiation protocol, expression of ePSC1aV3E, but
not ePSC1bV3E, caused a substantial decrease in the
Figure 3. Induction of processes
by overexpression of the RD of
novel PKC isoforms. SH-SY5Y
and SK-N-BE(2) cells were
transfected with expression vec-
tors coding for the RD of PKCa
(a), PKCb (b), PKCd (d), PKCe
(e), PKCh (h), or PKCu (u) fused
to EGFP or vector coding for
EGFP only. Cells were fixed 16 h
after transfection with 4% para-
formaldehyde and mounted on
object slides. (A) Fluorescent im-
ages of neuroblastoma cells ex-
pressing PKC–RD–EGFP fusion
proteins. The fluorescence from
EGFP made the entire cell visi-
ble. The cells shown are typical
for each treatment. For dRDE,
eRDE, and hRDE, cells with
processes are shown. The effect
of expression of EGFP only is
depicted in Fig. 2 A. (B and C)
Transfected SH-SY5Y (B) and
SK-N-BE(2) (C) cells with proces-
ses were counted. Data (mean 6
SEM, n 5 3–5) are presented as
percent transfected cells with
processes.The Journal of Cell Biology, Volume 145, 1999 720
number of neurite-bearing cells, both in control and
NGF-exposed cells. These results demonstrate that the
protein lacking the second C1 domain (ePSC1aV3) inhib-
its neurite outgrowth in several neuronal differentiation
protocols, whereas the protein with the first C1 domain
deleted (ePSC1bV3E) has no such effect.
To test whether the C1-deleted constructs have similar
effects on processes induced by overexpression of PKCe
or ePSC1V3E, eFLE and ePSC1V3E were cotransfected
with ePSC1aV3E or ePSC1bV3E at a 1:3 ratio into SK-
N-BE(2) cells (Fig. 6, C and D). Cotransfection with
ePSC1bV3E gave rise to fewer cells with processes than
when either eFLE or ePSC1V3E alone was transfected,
but substantially more process-bearing cells than when
ePSC1bV3E alone was transfected into the cells. It is likely
that the lower number of cells with processes in this
cotransfection protocol could be due to a significant pro-
portion of cells expressing only ePSC1bV3E, cells that will
fluoresce, but will not have processes. On the other
hand,  cotransfection with ePSC1aV3E gave a lower num-
ber of cells with processes than did cotransfection with
ePSC1bV3E. Thus, the ePSC1V3 fragment with the sec-
ond C1 domain deleted (ePSC1aV3E) acts in a dominant-
negative manner both suppressing processes induced by
overexpression of PKCe and inhibiting neurite outgrowth
in several neuronal differentiation protocols. This suggests
that the effect of the PSC1V3 region from PKCe may be a
common mechanism for these processes.
Characteristics of ePSC1V3E-induced Processes
All PKCe-derived, process-inducing constructs caused
similar morphological changes of transfected cells. The
outgrowth of processes was accompanied by a shrinkage
of the cytoplasm and a rounding up of the cell body, which
was most apparent in SK-N-BE(2) cells. Untreated SH-
SY5Y cells generally have smaller cell bodies than SK-
N-BE(2) cells, but a tendency towards rounding up of the
cell body was observed in the SH-SY5Y cells, also. The
overall morphology of the processes differed slightly be-
tween the two cell lines. In SH-SY5Y cells, generally one
process per cell was observed, but this process frequently
carried several branches of various lengths (Figs. 2 A, e; 3
A, d; and 4 A, PSC1V3), but in some cells two or more
processes extending from the same cell were seen (Fig. 3
A, e and h). The SK-N-BE(2) cells generally had more
than one process per cell, and these processes were fre-
quently branched.
To address whether the ePSC1V3E-induced processes
have characteristics associated with neurites, expression of
cytoskeletal components and synaptic markers were ana-
lyzed. The ePSC1V3E-induced processes in SH-SY5Y
Figure 4. Process-inducing ef-
fects of overexpression of differ-
ent parts of the RD of PKCe.
SH-SY5Y cells were transfected
with expression vectors coding
for  eRDE, eC2PSC1E, eC2PSE,
eC2E, ePSE, ePSC1aE, ePSC1E,
ePSC1V3E, eC1V3E, and eC1E
(see Fig. 1 for description of con-
structs). The cells were fixed and
mounted 16 h after transfection.
(A) Fluorescence images of SH-
SY5Y cells expressing the fusion
proteins were taken using a stan-
dard FITC filter. The cells
shown are typical for each
treatment. For eRDE and
ePSC1V3E, cells with processes
are shown. (B and C) Quantifi-
cation of the number of SH-
SY5Y (B) and SK-N-BE(2) (C)
transfectants with processes
longer than two cell bodies, ex-
pressed as percentage (mean 6
SEM, n 5 3–5) of transfected
cells for each construct.Zeidman et al. PKCe Regulatory Domain Induces Processes 721
cells were compared with neurites obtained after 4 d of
treatment with 16 nM TPA, a protocol that causes SH-
SY5Y cells to differentiate neuronally (Fig. 7). The experi-
ments show that both ePSC1V3E-induced processes and
the neurites of differentiated SH-SY5Y cells were com-
posed of a-tubulin (Fig. 7, A–D) and NF-160 (Fig. 7, E–H).
The cells were also stained for F-actin (Fig. 7, I–L), which
besides staining of the main branches of the processes, also
revealed an intense staining either at the tip of the pro-
cesses (Fig. 7 L) or at sites where the processes have sharp
bends (not shown). These actin-rich structures resemble
the growth cones in TPA-differentiated cells (Fig. 7 J),
suggesting that ePSC1V3E-induced processes express
growth cones. Staining for the presence of synaptic pro-
teins NPY (Fig. 7, M–P) and synaptophysin (Fig. 7, Q–T)
in TPA differentiated SH-SY5Y cells (Fig. 7, M, N, Q, and
R) was positive, while the processes of cells transfected
with ePSC1V3E were negative (Fig. 7, O, P, S, and T).
This shows that ePSC1V3E-induced processes are neurite-
like, but lack important properties of functional neurites.
Furthermore, no overall increase in the expression of NPY
or synaptophysin could be detected in the ePSC1V3E-
transfected cells, suggesting that this PKCe fragment does
not induce complete differentiation of neuroblastoma
cells. The characteristics of processes induced by eFLE
were similar to ePSC1V3E-induced processes (not shown).
Colocalization of PKCe–EGFP and F-Actin
An interesting issue is why overexpression of the RDs of
both PKCe and PKCd (eRDE and dRDE) induced pro-
cesses, whereas for full-length isoforms the same effect
only was obtained with PKCe (eFLE) and not with PKCd
(dFLE). A unique feature of PKCe, compared with other
isoforms, is the presence of an actin-binding site between
the C1 domains (Prekeris et al., 1996). Binding to F-actin
via this site in vitro has been shown to maintain PKCe in
an open conformation (Prekeris et al., 1998), which may
result in exposure of structures in the RD essential for the
process-inducing capacity of this isoform. If this interac-
tion is important for the process induction of eFLE, it
would be expected to detect colocalization of F-actin and
eFLE. F-actin in eFLE-transfected SH-SY5Y cells was
stained with Texas red–conjugated phalloidin and the
Figure 5. Localization of PKCe constructs determined by confo-
cal microscopy. SH-SY5Y cells were transfected with eFLE,
ePSC1V3E,  ePSC1E, and eC1V3E. 16 h after transfection the
cells were fixed and mounted, and the localization of the fusion
proteins was examined with confocal microscopy.
Figure 6. Inhibition of RA-, growth factor-, and PKCe-induced
processes by C1-deleted PKCe constructs. SK-N-BE(2) (A) and
SH-SY5Y/TrkA (B) cells were transfected with expression vec-
tors coding for ePSC1aV3E and ePSC1bV3E, or vector coding
for EGFP only (see Fig. 1 for description of constructs). After
transfection the cells were treated for 40 h with factors known to
promote differentiation of these cell lines: 10 mM RA or 25 ng/ml
CNTF for SK-N-BE(2) cells; and 100 ng/ml NGF for SH-SY5Y/
TrkA cells. The cells were fixed and mounted 40 h after transfec-
tion and the number of SK-N-BE(2) and SH-SY5Y/TrkA trans-
fectants with processes longer than two cell bodies were quanti-
fied. Data are expressed as percentage of transfected cells with
neurites (mean 6 SEM, n 5 3–4). (C and D) SK-N-BE(2) cells
were either transfected with indicated plasmids or subjected to
a cotransfection with eFLE (C) or ePSC1V3E (D), and
ePSC1V3aE or ePSC1V3bE, in a 1:3 ratio, and fixed and
mounted 16 h after transfection. A total amount of 2 mg DNA
was used for each transfection. Fluorescent cells with processes
were quantified and expressed as percentage (mean 6 SEM, n 5
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Figure 7. Phenotypic characterization of processes induced by ePSC1V3. SH-SY5Y cells overexpressing ePSC1V3E were compared
with TPA-differentiated SH-SY5Y cells for cytoskeletal composition and expression of synaptic proteins. 16 h after transfection with
ePSC1V3E, or after 4 d of treatment with 16 nM TPA of SH-SY5Y cells, the cells were fixed, and immunofluorescence with TRITC-
conjugated secondary antibodies or TRITC-phalloidin staining of F-actin was performed. TPA-differentiated (A, B, E, F, I, J, M, N, Q,
and R) and ePSC1V3E-expressing cells (C, D, G, H, K, L, O, P, S, and T) were analyzed for expression of a-tubulin (B and D), NF-160
(F and H), F-actin (J and L), NPY (N and P), and synaptophysin (R and T). ePSC1V3-transfected cells were visualized using the fluo-
rescence of EGFP (C, G, K, O, and S). The weak staining seen in P and T was similar to the background staining seen when only sec-
ondary antibody was used.Zeidman et al. PKCe Regulatory Domain Induces Processes 723
colocalization of F-actin and eFLE was analyzed with con-
focal microscopy. Several processes were analyzed and it
was evident that the proteins were colocalized in some
parts of the processes (Fig. 8). This result thus indicates
that an interaction between eFLE and F-actin may take
place in the processes.
Discussion
This study was designed to examine the role of PKC iso-
forms in neurite outgrowth regulation and identify struc-
tures in the PKC molecule of importance for its function in
this process. For this purpose, we used neuroblastoma cell
lines which have been extensively used to study neuronal
differentiation. Of the classical and novel PKC isoforms
that are consistently expressed in neuroblastoma cells
(PKCa, bII, d and e; Zeidman et al., 1999), only overex-
pression of PKCe induced processes in these cells. PKCe
has been suggested to be of importance for neurite out-
growth in PC12 cells where overexpression of PKCe, but
not PKCd, potentiated NGF-induced neurite outgrowth
(Hundle et al., 1995). The effect of PKCe in PC12 cells was
suppressed by PKC inhibitors, which contrasts the results
in the present study which demonstrates that the effect of
PKCe was independent of its kinase activity. Furthermore,
in PC12 cells, overexpression of PKCe did not by itself in-
duce processes. It is thus likely that PKCe may regulate
neurite outgrowth by a number of mechanisms. In neuro-
blastoma cells, several PKC isoforms are enriched in
growth cones, but studies with phorbol ester treatment,
which downregulates the classical isoforms, have sug-
gested a role for PKCe or another novel isoform in sup-
porting the growth cone (Fagerström et al., 1996). These
facts, together with the results from the present study,
highlight PKCe as one PKC isoform of importance in neu-
rite outgrowth regulation.
In this study, the PKC isoforms were fused to EGFP to
visualize transfected cells and to facilitate an examination
of the intracellular distribution of the expressed proteins.
EGFP, in its native fluorescent form, is a highly condensed
molecule (Ormö et al., 1996). Approaches to fuse PKC
isoforms with GFP variants have been successfully used to
follow the translocation of PKCbII (Feng et al., 1998),
PKCg (Sakai et al., 1997), PKCd (Ohmori et al., 1998; Shi-
rai et al., 1998), and PKCe (Shirai et al., 1998). When ex-
amined, this fusion has been shown not to influence the
catalytic activity of the enzyme. GFP variants have also
been fused to smaller proteins or isolated domains, such as
histone 2B (Kanda et al., 1998), pleckstrin homology do-
mains (Stauffer et al., 1998), and PKC C1 domains (Oan-
cea et al., 1998) without any obvious loss of function. Fur-
thermore, as shown in this study, regardless if the position
of EGFP was at the COOH terminus of intact PKCe or if
it was placed COOH-terminally of the RD in constructs
where the catalytic domain was deleted, processes were in-
duced in neuroblastoma cells. This suggests that the effect
on the process induction is independent of the position of
EGFP. Processes were also induced when PKCe, without
being fused to EGFP, was overexpressed. Several subdo-
mains of PKCe that were fused to EGFP did not induce
processes at all, further indicating that the effects observed
in this study are not mediated by EGFP.
As previously mentioned, the effect of PKCe was inde-
pendent of enzymatic activity and of the presence of the
catalytic domain, since expression of the RD was sufficient
to induce processes. In fact, the RD could induce pro-
cesses more potently than the full-length PKCe, suggesting
that the catalytic domain may inhibit this function of the
RD. The RD from PKCd and h also induced processes in
the transfected cells, despite the inability of full-length
PKCd to do so. Cells transfected with uRDE displayed less
fluorescence than the other RD transfectants, probably in-
dicating a lower level of expression of fusion protein in
these transfectants. It is possible that the RD from PKCu
Figure 8. Colocalization of
PKCe–EGFP and F-actin. F-actin
in SH-SY5Y cells overexpress-
ing  eFLE was stained with Texas
red–conjugated phalloidin and
colocalization of the proteins
was analyzed with confocal mi-
croscopy. Confocal images of a
process demonstrate localiza-
tion of eFLE (A), Texas red–
phalloidin-labeled F-actin (B), and a merger of the two images
(C). The graph (D) shows the EGFP and Texas red intensity of
each pixel in C. Pixels which display fluorescence from both
EGFP and Texas red, indicating colocalization of eFLE and
F-actin, are included in the rectangle in D and shown in white in
E. Similar experiments analyzing each fluorophore by itself dem-
onstrated that there was no leakage of fluorescent signal into the
other channel. The result, colocalization in some parts of the pro-
cesses, is representative of six processes from two separate exper-
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would have had the same effect if the protein levels in
each individual cell had been higher. These results may
suggest that the novel isoforms PKCd and PKCh, and per-
haps PKCu, could have the capacity to induce processes
under proper conditions. An interesting feature possibly
explaining the selective effect of full-length PKCe, is the
actin binding site which is present only in this isoform
(Prekeris et al., 1996). When PKCe binds actin it is main-
tained in an open active confirmation exposing the cata-
lytic domains and the RDs (Prekeris et al., 1998), which
thereby can exert its activity. There was a colocalization of
eFLE and F-actin in processes, a finding which may indi-
cate that this interaction might be important for the selec-
tive effect of PKCe, although further experimentation is
necessary to establish this interaction as crucial for process
induction.
The finding that the PKCe effect is insensitive to PKC
inhibitors and could be mimicked by the RD is somewhat
surprising. Since RDs of PKC isoforms have been sug-
gested to act in a dominant-negative manner, the effects
obtained in this study may be due to a dominant-negative
effect of PKCe and its RD on another endogenous PKC
isoform. If this were the case, it would be expected to see
an induction of processes upon inhibition of this isoform
with PKC inhibitors. However, treatment of the neuro-
blastoma cells with GF109203X did not cause an elevated
number of processes. It could be argued that this lack of
process induction is due to the fact that GF109203X also
inhibits other kinases that are critical for the induction of
processes. If so, it would be expected that GF109203X
should suppress the processes also in PKCe-overexpress-
ing cells, since the kinase of importance for processes also
would be inhibited under these conditions. Furthermore, if
the effects of the PKCe constructs are dominant-negative,
the suppression by ePSC1aV3E of PKCe-induced pro-
cesses, RA-, and NGF-induced neurites implies that this
construct would act in a dominant-negative manner to-
wards a dominant-negative effect in the first case, whereas
in the latter protocols it would simply act in a dominant-
negative way. Therefore, we think that the most plausible
explanation for the effects observed in this paper is that
PKCe RD induces processes through a mechanism that
does not involve dominant-negative effects.
There are other reports where parts of, or the entire
PKC RD exert the same effects as the complete enzyme.
PKCa was shown to activate phospholipase D in a PKC
activator-dependent, but PKC activity-independent fash-
ion, and phospholipase D was activated by PKCa regula-
tory, but not catalytic domain in vitro (Singer et al., 1996).
Another example is the inhibition of Golgi-specific sulfa-
tion of glycosaminoglycan chains in cells overexpressing
PKCe, which can be mimicked by overexpressing the
PKCe C1 domains only (Lehel et al., 1995a).
When examining the role of the different domains of
PKCe RD in process induction, it was evident that a frag-
ment centering on the two C1 domains was sufficient and
necessary for this effect. Interestingly, the C2 domain,
which is of importance for RACK binding (Csukai et al.,
1997), was not of importance for the process-inducing ca-
pacity. In fact, expression in SH-SY5Y cells suggested that
removal of the C2 domain from the RD, generating
PSC1V3, slightly increased the ability to induce processes.
There are several examples demonstrating that protein in-
teraction with the RD is mediated via the C1 domains. Be-
side the previously mentioned actin binding site in PKCe
located between the C1 domains (Prekeris et al., 1996), a
homologue of 14-3-3 has been shown to bind the Dictyo-
stelium myosin II heavy chain-specific PKC through the
PKC C1 domain (Matto-Yelin et al., 1997). In addition,
binding of the pleckstrin homology domain from the ty-
rosine kinase Btk was shown to be dependent on the pseu-
dosubstrate and the C1 domain from PKCe (Yao et al.,
1997). Using an overlay assay, it was shown that the sec-
ond C1 domain from PKCg bound several proteins from
Xenopus laevis oocyte cytosol extracts (Pawelczyk et al.,
1998). Taken together, these results indicate an important
role for the C1 domains in PKC protein interactions. Thus,
it is conceivable that the effects observed in this study are
due to the C1 domains interacting with other proteins,
thereby eliciting the observed morphological changes.
However, there was also a dependence on the pseudosub-
strate and parts of the V3 domain for the induction of pro-
cesses. These structures have been shown to be of impor-
tance for localization of PKCe C1 domains to the plasma
membrane in NIH3T3 fibroblasts (Lehel et al., 1995b).
In line with that report, the process-inducing fragment,
PSC1V3, localized almost exclusively to the plasma mem-
brane, but this localization was lost when the pseudosub-
strate was removed. This was accompanied with a loss of
process-inducing capacity, which suggests that a plasma
membrane localization is necessary for this effect. How-
ever, a plasma membrane localization per se of the C1 do-
mains is not sufficient, since the PSC1 fragment to a large
extent appeared to be present at the plasma membrane
without inducing processes.
Removal of the second, but not of the first, C1 domain
generated a fragment that suppressed neurite outgrowth
during RA-, CNTF-, and NGF-driven neuronal differenti-
ation. Since this same fragment also acted in a dominant-
negative manner towards processes induced by PKCe
overexpression, these results suggest that the observed ef-
fects of PKCe is not only observed upon overexpression of
the protein, but may indeed be of importance for neu-
rite outgrowth that accompanies neuronal differentiation.
However, given the abundance of proteins with C1 do-
mains (Hurley et al., 1997), it cannot be excluded that dur-
ing neuronal differentiation effects reported in this study
are mediated via other C1 containing proteins. The results
obtained with the C1-deleted constructs also illustrate the
different properties of the two C1 domains that have been
described (Szallasi et al., 1996; Hunn and Quest, 1997;
Bögi et al., 1998).
From the present results, it is not possible to draw defi-
nite conclusions regarding the mechanisms whereby PKCe
constructs elicit processes. To exclude the possibility that
the increase in process-bearing cells is not due to a selec-
tion of cells with process-inducing capacity, the number
of SH-SY5Y cells expressing EGFP or eRDE following
transfection were counted. There was a lower percentage
of eRDE-expressing cells (4.1 6 0.5% of EGFP- versus
2.8 6 0.6% eRDE-expressing cells), but this difference is
too low to account for the increase in process-bearing cells
(#5% in EGFP- to 32% in eRDE-expressing cells). Fur-
thermore, the few processes that could be observed inZeidman et al. PKCe Regulatory Domain Induces Processes 725
EGFP-expressing cells were much shorter than processes
in cells transfected with PKCe constructs. This was also
true for EGFP-expressing cells that were kept in culture
for up to 4 d. This suggests that transfection with PKCe
constructs does not result in an enhancement of a basal
rate of process generation, but rather induces some events
that eventually lead to the generation of neurite-like pro-
cesses. This process generation may be mediated via cy-
toskeletal mechanisms, effects on the interaction of the
cell with the substratum, or some other mechanism. It
does not seem to involve altered expression of differentia-
tion-coupled genes, since no increase in expression of
NPY or synaptophysin, in the cell bodies or the processes,
could be observed in ePSC1V3E-overexpressing cells.
These proteins are elevated upon neuronal differentiation
of neuroblastoma cells. Thus, it is likely that PKCe overex-
pression induces processes in undifferentiated cells and
does not elicit a complete neuronal differentiation pro-
gram. Both a-tubulin and NF-160 were present at appar-
ently similar levels in the processes in ePSC1V3E-overex-
pressing cells and in neurites in neuronally differentiated
neuroblastoma cells, indicating that the processes induced
by the PKCe fragment to some extent display neuronal
features. Such a dissociation between the physical induc-
tion of neurites and the accompanying increase in neu-
ronal differentiation markers generally present in neurites
has also been observed after overexpression of a constitu-
tively active phosphatidylinositol 3 kinase in PC12 cells
(Kobayashi et al., 1997).
In conclusion, this study demonstrates that PKCe, but
not PKCa, bII, or d, induces neurite-like processes in neu-
roblastoma cells and this effect can be ascribed to a region
encompassing the pseudosubstrate, the two C1 domains,
and parts of the V3 domain. Identification of a dominant-
negative construct derived from this region indicates that
this effect of PKCe is of relevance for neurite outgrowth
during neuronal differentiation.
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